The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward

doi:10.1186/1479-5876-6-8

Journal of Translational Medicine
Volume 6

Viewing options:

Abstract
Full text
PDF (372KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Maio M
Nicolay HJ
Ascierto P
Belardelli F
Camerini R
Colombo MP
Queirolo P
Ridolfi R
Russo V
Anzalone L
Fonsatti E
Parmiani G

on PubMed

Maio M
Nicolay HJ
Ascierto P
Belardelli F
Camerini R
Colombo MP
Queirolo P
Ridolfi R
Russo V
Anzalone L
Fonsatti E
Parmiani G
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Commentary

The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward

Michele Maio¹^,2 , Hugues JM Nicolay¹^,2 , Paolo Ascierto³ , Filippo Belardelli⁴ , Roberto Camerini⁵ , Mario P Colombo⁶ , Paola Queirolo⁷ , Ruggero Ridolfi⁸ , Vincenzo Russo⁹ , Lucia Anzalone¹ , Ester Fonsatti¹ and Giorgio Parmiani¹⁰

¹Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy

²Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy

³Unit of Clinical Immunology, Istituto Nazionale Tumori "Fondazione Pascale" Naples, Italy

⁴Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy

⁵Clinical Research Unit III, Sigma Tau SpA, Rome, Italy

⁶Immunotherapy and Gene Therapy Unit, Department of Experimental Oncology, Fondazione Istituto Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy

⁷Department of Medical Oncology A, National Institute for Cancer Research, Genova, Italy

⁸Immunotherapy and Somatic Cell Therapy Unit, Istituto Scientifico Romagnolo per lo studio e la cura dei tumori, Forlì, Italy

⁹Cancer Gene Therapy Unit, Department of Oncology, Scientific Institute S. Raffaele, Milan, Italy

¹⁰Department of Oncology, San Raffaele Scientific Institute, Milan, Italy

author email corresponding author email

Journal of Translational Medicine 2008, 6:8doi:10.1186/1479-5876-6-8


Published:	12 February 2008

Abstract

As for a consolidated tradition, the 5^thannual meeting of the Italian Network for Cancer Biotherapy took place in the Certosa of Pontignano, a Tuscan monastery, on September 20–22, 2007. The congress gathered more than 40 Italian leading groups representing academia, biotechnology and pharmaceutical industry. Aim of the meeting was to share new advances in cancer bio-immunotherapy and to promote their swift translation from pre-clinical research to clinical applications. Several topics were covered including: a) molecular and cellular mechanisms of tumor escape; b) therapeutic antibodies and recombinant constructs; c) clinical trials up-date and new programs; d) National Cooperative Networks and their potential interactions; e) old and new times in cancer immunology, an "amarcord". Here, we report the main issues discussed during the meeting.